BR9900116A - Comprimido de mesilato de trovafloxacina. - Google Patents

Comprimido de mesilato de trovafloxacina.

Info

Publication number
BR9900116A
BR9900116A BR9900116-0A BR9900116A BR9900116A BR 9900116 A BR9900116 A BR 9900116A BR 9900116 A BR9900116 A BR 9900116A BR 9900116 A BR9900116 A BR 9900116A
Authority
BR
Brazil
Prior art keywords
trovafloxacin mesylate
mesylate tablet
diluent
tablet
trovafloxacin
Prior art date
Application number
BR9900116-0A
Other languages
English (en)
Inventor
Alton Dale Johnson
Christopher Michael Sinko
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BR9900116A publication Critical patent/BR9900116A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Patente de Invenção: <B>"COMPRIMIDO DE MESILATO DE TROVAFLOXACINA"<D>. Composições, especialmente na forma de comprimidos contendo a forma do polimorfo II de mesilato de trovafloxacina, um lubrificante, e celulose microcristalina (MC) como diluente. Tais composições empregando MC como um diluente exibem boas propriedades de estabilidade no armazenamento e de dissolução.
BR9900116-0A 1998-01-21 1999-01-19 Comprimido de mesilato de trovafloxacina. BR9900116A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7201398P 1998-01-21 1998-01-21

Publications (1)

Publication Number Publication Date
BR9900116A true BR9900116A (pt) 2000-05-02

Family

ID=22105016

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9900116-0A BR9900116A (pt) 1998-01-21 1999-01-19 Comprimido de mesilato de trovafloxacina.

Country Status (34)

Country Link
US (1) US6187341B1 (pt)
EP (1) EP0930068A3 (pt)
JP (1) JPH11269072A (pt)
KR (1) KR100314977B1 (pt)
CN (1) CN1227743A (pt)
AP (1) AP1094A (pt)
AR (1) AR012780A1 (pt)
AU (1) AU758381B2 (pt)
BG (1) BG103106A (pt)
BR (1) BR9900116A (pt)
CA (1) CA2259698C (pt)
CO (1) CO4810225A1 (pt)
DZ (1) DZ2712A1 (pt)
EA (1) EA003247B1 (pt)
GT (1) GT199900004A (pt)
HR (1) HRP990023A2 (pt)
HU (1) HUP9900154A3 (pt)
ID (1) ID23735A (pt)
IL (1) IL128051A0 (pt)
IS (1) IS4947A (pt)
MA (1) MA24747A1 (pt)
NO (1) NO990243L (pt)
NZ (1) NZ333838A (pt)
OA (1) OA10958A (pt)
PA (1) PA8466701A1 (pt)
PE (1) PE20000169A1 (pt)
PL (1) PL330981A1 (pt)
SG (1) SG70666A1 (pt)
SK (1) SK4299A3 (pt)
TN (1) TNSN99007A1 (pt)
TR (1) TR199900089A3 (pt)
TW (1) TW518224B (pt)
YU (1) YU2399A (pt)
ZA (1) ZA99393B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA72483C2 (en) * 1998-11-10 2005-03-15 Moxifloxacin-containing pharmaceutical preparation and method for its manufacture
CA2382834A1 (en) * 1999-09-20 2001-03-29 Alza Corporation Process for lessening polymorphic conversion of a drug
PE20010635A1 (es) * 1999-10-08 2001-08-15 Smithkline Beecham Corp Inhibidores de fab i utiles para el tratamiento de infecciones bacterianas
FR2808441B1 (fr) * 2000-05-04 2004-06-18 Oreal Utilisation de fibres dans une composition de soin ou de maquillage pour matifier la peau
DE10031043A1 (de) * 2000-06-26 2002-02-14 Bayer Ag Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
DE60230934D1 (de) * 2001-04-06 2009-03-05 Affinium Pharm Inc Fab-i-inhibitoren
EP1396263A1 (en) 2002-08-09 2004-03-10 Warner-Lambert Company Film coating for tablets and caplets
ES2518316T3 (es) * 2002-12-06 2014-11-05 Debiopharm International Sa Compuestos heterocíclicos, métodos de fabricación de los mismos y su uso en terapia
CN100415284C (zh) * 2002-12-30 2008-09-03 毛友昌 六味木香片的制备方法
DE602004016831D1 (de) 2003-03-17 2008-11-13 Affinium Pharm Inc Pharmazeutische zusammensetzungen inhibitoren von fab i und weitere antibiotika enthaltend
ATE382338T1 (de) * 2003-03-19 2008-01-15 Jordanian Pharmaceutical Mfg Nicht-hygroskopische pharmazeutische zusammensetzungen die nicht hydratisierte quinolon-carbonsäure enthalten
US8906413B2 (en) 2003-05-12 2014-12-09 Supernus Pharmaceuticals, Inc. Drug formulations having reduced abuse potential
CA2531637A1 (en) * 2003-07-23 2005-02-03 L. Perrigo Company Cellulosic fiber containing composition
CA2568914C (en) 2004-06-04 2013-09-24 Affinium Pharmaceuticals, Inc. Therapeutic agents, and methods of making and using the same
EP1809259B1 (en) * 2004-10-15 2014-12-03 Supernus Pharmaceuticals, Inc. Less abusable pharmaceutical preparations
US20090156578A1 (en) * 2005-12-05 2009-06-18 PAULS Henry 3-Heterocyclylacrylamide Compounds as Fab I Inhibitors and Antibacterial Agents
EP2687533B1 (en) 2006-07-20 2017-07-19 Debiopharm International SA Acrylamide derivatives as FAB I inhibitors
EP2125802A4 (en) 2007-02-16 2014-08-20 Debiopharm Int Sa SALTS, PRODRUGS AND POLYMORPHES OF FAB I INHIBITORS
PL2861608T3 (pl) 2012-06-19 2019-09-30 Debiopharm International Sa Pochodne prolekowe (e)-n-metylo-n-((3-metylobenzofuran-2-ylo)metylo)-3-(7-okso-5,6,7,8-tetrahydro-1,8-naftyrydyn-3-ylo)akryloamidu
US10751351B2 (en) 2016-02-26 2020-08-25 Debiopharm International S.A. Medicament for treatment of diabetic foot infections

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5286754A (en) 1986-01-21 1994-02-15 Bayer Aktiengesellschaft Pharmaceutical formulations of ciprofloxacin
DE3601566A1 (de) * 1986-01-21 1987-07-23 Bayer Ag Pharmazeutische zubereitungen von ciprofloxacin
US4957554A (en) 1989-08-16 1990-09-18 Minnesota Mining And Manufacturing Company Dimensionally-controlled ceramics
DE4120646A1 (de) 1991-06-22 1992-12-24 Bayer Ag 7-isoindolinyl-chinolon- und naphthyridoncarbonsaeure-derivate
CN1190889A (zh) * 1995-08-29 1998-08-19 美国辉瑞有限公司 曲氟沙星的两性离子形式

Also Published As

Publication number Publication date
HUP9900154A3 (en) 2000-12-28
TR199900089A2 (xx) 1999-10-21
CA2259698C (en) 2003-04-15
PA8466701A1 (es) 2000-09-29
BG103106A (en) 1999-08-31
TNSN99007A1 (fr) 2005-11-10
OA10958A (en) 2001-10-31
JPH11269072A (ja) 1999-10-05
IL128051A0 (en) 1999-11-30
HUP9900154A2 (hu) 1999-09-28
NO990243D0 (no) 1999-01-20
AR012780A1 (es) 2000-11-08
TR199900089A3 (tr) 1999-10-21
EA199900046A2 (ru) 1999-08-26
PL330981A1 (en) 1999-08-02
CO4810225A1 (es) 1999-06-30
GT199900004A (es) 2000-07-08
KR19990068014A (ko) 1999-08-25
ZA99393B (en) 2000-07-21
ID23735A (id) 2000-05-11
IS4947A (is) 1999-07-22
AP9901443A0 (en) 1999-03-31
DZ2712A1 (fr) 2003-09-01
CA2259698A1 (en) 1999-07-21
EP0930068A3 (en) 1999-12-22
NZ333838A (en) 2000-03-27
SK4299A3 (en) 2000-06-12
US6187341B1 (en) 2001-02-13
NO990243L (no) 1999-07-22
TW518224B (en) 2003-01-21
AU758381B2 (en) 2003-03-20
SG70666A1 (en) 2000-02-22
HRP990023A2 (en) 1999-08-31
HU9900154D0 (en) 1999-03-29
AU1217399A (en) 1999-08-12
AP1094A (en) 2002-08-19
EA003247B1 (ru) 2003-02-27
KR100314977B1 (ko) 2001-11-24
CN1227743A (zh) 1999-09-08
YU2399A (sh) 2002-06-19
MA24747A1 (fr) 1999-10-01
EA199900046A3 (ru) 1999-12-29
PE20000169A1 (es) 2000-03-10
EP0930068A2 (en) 1999-07-21

Similar Documents

Publication Publication Date Title
BR9900116A (pt) Comprimido de mesilato de trovafloxacina.
TNSN99126A1 (fr) Pyrrolopyrimidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
WO2002098856A3 (en) Piperazine oxyquinoline (naphthaline) platelet adenosine diphosphate receptor antagonists
NO20024339D0 (no) 1,2,3,4-Tetrahydroisokinolin-derivater
DK1177187T3 (da) Diarylsyrederivater som PPAR-receptorligander
HUP0203973A3 (en) Heterocyclic compounds having sulfonamide groups, pharmaceutical compositions containing them and their use
DE60045528D1 (de) Pharmazeutische zusammensetzungen, die ccr5-antagonisierende piperazinderivate enthalten
NO20015226L (no) Tri-aryl syrederivater som PPAR reseptor ligander, farmasoytisk sammensetning omfattende samme og anvendelse av samme for fremstilling av medikament.
MA27589A1 (fr) Composes a base d&#39;indazole, compositions pharmaceutiques et methodes pour modifier legerement ou inhiber la proliferation de cellules
BR9911575A (pt) Heterocìclicos de alquilsulfóxido 4-benzil piperidina e seu uso como antagonistas receptores de nmda seletivas do subtipo
TNSN99125A1 (fr) Pyrrolo(2,3-d) pyrimidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
AU2002315256A1 (en) Aqueous composition containing a polymer or copolymer of a 3,4-dialkoxythiophene and a non-newtonian binder
HUP0103344A3 (en) Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp), process for their preparation and pharmaceutical compositions containing them
BR0208741A (pt) Derivados de piperidina
HUP0301577A3 (en) Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors, pharmaceutical compositions containing them and their use
HUP0101333A3 (en) Diazepan derivatives and their salts, pharmaceutical compositions containing the same
HUP0103431A3 (en) Pharmaceutical, oral compositions containing 5-ht4 agonists or antagonists as active agent
CA2429639A1 (en) Stable azithromycin monohydrate
IS2481B (is) Lyfjablanda sem inniheldur 5HT1 viðtakagerandefni
TNSN01175A1 (fr) Derives de piperidines antagonistes selectives de sous- types de recepteurs de nmda, et compositions les contenant.
MXPA03001610A (es) Derivados de acido oxazolil-arilpropionico y su uso como agonistas de los receptores activados por proliferadores de peroxisomas.
BR0003233A (pt) Pirazol, uso do composto na preparação de um medicamento e composição
WO2001010860A3 (en) Quinazolinone and azaquinazolinone derivatives
TNSN99146A1 (fr) Derives de 1-heteroaryl-pyrrolidine, -piperidine et - homopiperidine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
EA200300128A1 (ru) Фармацевтические композиции, содержащие карбонат лития

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6,7 E 8A ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1910 DE 14/08/2007.

B15K Others concerning applications: alteration of classification

Ipc: A61K 9/28 (2006.01), A61K 9/20 (2006.0